Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies

被引：9
|
作者：
Bientinesi, Riccardo [1 ]
Gandi, Carlo [1 ]
Bassi, PierFrancesco [1 ]
机构：
[1] Catholic Univ, Agostino Gemelli Hosp Fdn IRCCS, Dept Urol, Med Sch, Rome, Italy
来源：
INTERNATIONAL NEUROUROLOGY JOURNAL | 2020年 / 24卷 / 02期
关键词：
Multiple sclerosis; Lower urinary tract symptoms; Urinary incontinence; Neurogenic detrusor overactivity; DETRUSOR-SPHINCTER DYSSYNERGIA; URINARY-TRACT DYSFUNCTION; TIBIAL NERVE-STIMULATION; SPINAL-CORD-INJURY; BOTULINUM-A TOXIN; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; SEXUAL DYSFUNCTION; DOUBLE-BLIND; ELECTRICAL-STIMULATION;
D O I：
10.5213/inj.2040028.014
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Multiple sclerosis (MS) is a progressive neurological autoimmune disease with a diverse range of urological symptomatology, and most MS patients experience 1 or more moderate to severe urinary symptoms, as well as bladder and/or sexual disorders. Urologists play the director's role in evaluating and treating these patients. Therefore, identifying the proper evaluation tools and the most suitable therapeutic options for specific patients requires a thorough understanding of this disease process.
引用
收藏
页码：118 / 126
页数：9
相关论文
共 50 条
  • [21] Emerging monoclonal antibody therapies for multiple sclerosis
    Cree, Bruce
    [J]. NEUROLOGIST, 2006, 12 (04) : 171 - 178
  • [22] Current and Emerging Therapies for Multiple Sclerosis Preface
    Keegan, B. Mark
    [J]. SEMINARS IN NEUROLOGY, 2013, 33 (01) : 3 - 3
  • [23] Managing the Quality of Life in Patients with Multiple Sclerosis: A Literature Review
    Kefaliakos, Antonios
    Pliakos, Ioannis
    Diomidous, Marianna
    [J]. UNIFYING THE APPLICATIONS AND FOUNDATIONS OF BIOMEDICAL AND HEALTH INFORMATICS, 2016, 226 : 220 - 221
  • [24] Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies
    DasGupta, R
    Fowler, CJ
    [J]. CURRENT OPINION IN NEUROLOGY, 2002, 15 (03) : 271 - 278
  • [25] A review of possible therapies for multiple sclerosis
    Li, Hui
    Lian, Gaojian
    Wang, Guang
    Yin, Qianmei
    Su, Zehong
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (09) : 3261 - 3270
  • [26] Perspectives on urological care in multiple sclerosis patients
    Moussa, Mohamad
    Abou Chakra, Mohamad
    Papatsoris, Athanasios G.
    Dabboucy, Baraa
    Hsieh, Michael
    Dellis, Athanasios
    Fares, Youssef
    [J]. INTRACTABLE & RARE DISEASES RESEARCH, 2021, 10 (02) : 62 - 74
  • [27] A review of possible therapies for multiple sclerosis
    Hui Li
    Gaojian Lian
    Guang Wang
    Qianmei Yin
    Zehong Su
    [J]. Molecular and Cellular Biochemistry, 2021, 476 : 3261 - 3270
  • [28] UROLOGICAL COMPLICATIONS IN PATIENTS WITH MULTIPLE-SCLEROSIS
    KIESSWETTER, H
    FLAMM, J
    HENNRICH, F
    SUMMER, K
    SCHOBER, W
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1980, 92 (01) : 16 - 22
  • [29] Emerging therapies to target CNS pathophysiology in multiple sclerosis
    Jiwon Oh
    Amit Bar-Or
    [J]. Nature Reviews Neurology, 2022, 18 : 466 - 475
  • [30] Treatment Options for Multiple Sclerosis: Current and Emerging Therapies
    Gawronski, Kristen M.
    Rainka, Michelle M.
    Patel, Malti J.
    Gengo, Francis M.
    [J]. PHARMACOTHERAPY, 2010, 30 (09): : 916 - 927
12345